Institution
Saint Francis University
Education•Loretto, Pennsylvania, United States•
About: Saint Francis University is a education organization based out in Loretto, Pennsylvania, United States. It is known for research contribution in the topics: Population & Osteoblast. The organization has 1694 authors who have published 2038 publications receiving 87149 citations.
Topics: Population, Osteoblast, Growth factor, Bone cell, Bone remodeling
Papers published on a yearly basis
Papers
More filters
••
TL;DR: In this article, the authors consider the ways in which humans have identified with animals as animals, and the introduction of the animal as animal into the discussion of human culture reveals a level of complexity in life and history that is all too easily overlooked.
Abstract: Several important studies of animals in Victorian Britain have considered the ways that animals have served as surrogates for the discussion of human relationships. Historical statements about the treatment of animals are often interpreted as telling stories about issues such as class dynamics or social problems among humans. But must one always imagine animals to have been only the ostensible subject of discussion? While it is certainly important to study how historical discussions about animals have reflected and expressed opinions about sensitive, tense, or otherwise difficult relationships among humans and groups of humans, it is unreasonable to dismiss all discussion of the welfare of animals as a cover for what is really a concern about humans. Is it not just as interesting – and important – to consider the ways in which humans have identified with animals as animals? The introduction of the animal as animal into the discussion of human culture reveals a level of complexity in life and history that is all too easily overlooked.
8 citations
••
TL;DR: EHR systems used by many pediatric clinic practices do not meet the standard set forth by the AAP, and it is imperative that medical technology tools adequately consider pediatric needs during development and that this is reflected in selected EHR systems.
8 citations
••
TL;DR: The case of a 54-year-old woman who developed native valve infective endocarditis due to Micrococcus luteus is reported, which is thought to be the first reported case of its kind in the UK.
8 citations
••
TL;DR: Optimization of passive biological treatment systems targeting conductivity requires an increase in the number of published conductivity datasets from similar systems, detailed reports on the key ions contributing to elevated conductivity region to region, and further investigation of the underlying biochemical processes responsible for conductivity reductions.
Abstract: The remediation of mine water to preserve receiving water quality has advanced substantially over the past half century, but prospective regulations to limit the conductivity of mining-impacted waters pose a significant new challenge. Conventional approaches to reduce high levels of conductivity in these mine waters are often costly, requiring high levels of maintenance and significant inputs of energy and refined chemicals. In contrast, passive biological treatment (PBT) systems are a relatively low-cost, low-maintenance treatment technology for mine waters that have been used for over three decades. However, their practical ability to reduce conductivity is unclear, given previous research reports focused on the removal of metals, acidity, and solids. A systematic literature review to identify previous reports of PBT systems at the laboratory or field scale that include evaluations of changes in conductivity suggests that decreases in conductivity of 30 to 40% are achievable. Substantial variability in performance is common, however, and conductivity increased markedly in some systems. This variation may be associated with the dissolution of limestone, which is a key treatment material in some systems. Although the development of PBT to serve as pre-, post-, or stand-alone treatment systems targeting conductivity may reduce overall treatment cost in some settings, optimization of these designs requires an increase in the number of published conductivity datasets from similar systems, detailed reports on the key ions contributing to elevated conductivity region to region, and further investigation of the underlying biochemical processes responsible for conductivity reductions.
8 citations
••
TL;DR: TAVR is a promising option in AR and further studies are necessary for the expansion of TAVR as the standard treatment in AR, where anemia was predictive of increased overall complications and valvular complications, whereas peripheral vascular disease was a predictor of increased valvULAR complications and CHB/PPM.
Abstract: BACKGROUND Transcatheter aortic valve replacement (TAVR) can be an effective option for high-risk Aortic Regurgitation (AR) patients. Although international experiences of TAVR for AR are published, U.S. data are limited. This study sought to report the short-term outcomes of TAVR in AR in the U.S. POPULATION METHODS Study cohorts were derived from the Nationwide Inpatient Sample (NIS) and Nationwide Readmissions Database (NRD) 2016-17. TAVR and AR were identified using ICD-10-CM-codes. The key outcomes were all-cause mortality, disabling stroke, valvular complications, complete heart block (CHB)/permanent pacemaker placement (PPM), open-heart surgery, acute kidney injury (AKI) requiring dialysis, and vascular complications. Multivariate logistic regression was used to adjust for confounders. RESULTS 915 patients from the NIS (male-71%, age ≥65-84.2%) and 822 patients from the NRD (male-69.3%, age ≥65-80.5%) underwent TAVR for AR. The median length of stay (LOS) was 4 days for both cohorts. In-hospital mortality was 2.7%, and 30-day mortality was 3.3%. Disabling strokes were noted in 0.6% peri-procedurally and 1.8% at 30-days. Valve-related complications were 18-19% with paravalvular leak (4-7%) being the most common. Approximately 11% of patients developed CHB and/or needed PPM in both cohorts. In NRD, 2.2% of patients required dialysis for AKI, 1.5% developed vascular complications, and 0.6% required open-heart surgery within 30-days post-procedure. Anemia was predictive of increased overall complications and valvular complications, whereas peripheral vascular disease was a predictor of increased valvular complications and CHB/PPM. CONCLUSION TAVR is a promising option in AR. Further studies are necessary for the expansion of TAVR as the standard treatment in AR.
8 citations
Authors
Showing all 1697 results
Name | H-index | Papers | Citations |
---|---|---|---|
Steven M. Greenberg | 105 | 488 | 44587 |
Linus Pauling | 100 | 536 | 63412 |
Ernesto Canalis | 98 | 331 | 30085 |
John S. Gottdiener | 94 | 316 | 49248 |
Dalane W. Kitzman | 93 | 474 | 36501 |
Joseph F. Polak | 91 | 406 | 38083 |
Charles A. Boucher | 90 | 549 | 31769 |
Lawrence G. Raisz | 82 | 315 | 26147 |
Julius M. Gardin | 76 | 253 | 38063 |
Jeffrey S. Hyams | 72 | 357 | 22166 |
James J. Vredenburgh | 65 | 280 | 18037 |
Michael Centrella | 62 | 120 | 11936 |
Nathaniel Reichek | 62 | 248 | 22847 |
Gerard P. Aurigemma | 59 | 212 | 17127 |
Thomas L. McCarthy | 57 | 107 | 10167 |